`
`
`
`
`
`
`Paper No. 18
`Filed on Feb. 9, 2018
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`AFTON CHEMICAL CORPORATION
`Petitioner
`v.
`INFINEUM INTERNATIONAL LIMITED
`Patent Owner
`
`
`
`
`IPR2017-01321
`Patent 8,076,274
`
`
`
`NOTICE OF PETITIONER’S OBJECTIONS TO
`PATENT OWNER’S RESPONSE EVIDENCE
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.64(b)(1), Petitioner, Afton Chemical
`
`Case No. IPR2017-01321
`
`Corporation, hereby submits its objections to evidence served by Patent Owner,
`
`Infineum International Limited, Inc. with its Patent Owner Response and Motion to
`
`Amend. These objections are being filed on Feb. 9, 2018, and are timely, having
`
`been filed within five business days of the service of Patent Owner’s Response
`
`Evidence.
`
`Petitioner generally objects to the Exhibits to the extent they are not relevant
`
`(FRE 401, 402, 403), are outside the scope of the institution, lack foundation, for
`
`hearsay, are untimely, or are incomplete. Petitioner objects to the following
`
`Exhibits in their entirety.
`
`Exhibit 2017 was published in 2017; Exhibit 2018 was published in 2010,
`
`Exhibit 2019 was published in 2007; Exhibit 2020 was published in 2016; Exhibit
`
`2020 was published in 2011; and Exhibit 2024 was published in 2010 and updated
`
`in 2017; therefore, these Exhibits confuse the issues with information that was
`
`published after the ‘274 patent’s priority date. Exhibits 2017 and 2018 are Material
`
`Safety Data Sheets (MSDS) for Irganox L57, published in 2017 and 2010,
`
`respectively, which are merely more recent publication of the MSDS for the same
`
`product, Irganox L57, as Petitioner’s Exhibit 1026. Exhibits 2019 and 2020 are
`
`Material Safety Data Sheets (MSDS) for Irganox 5057, published in 2007 and
`
`2016, respectively, and are erroneously identified in the Exhibit Table as MSDS
`
`-1-
`
`
`
`
`for Irganox L57. Exhibit 2031 (EP 1 167 497 A2 to Nakazato) has already been
`
`Case No. IPR2017-01321
`
`entered into the record as Exhibit 1019, and thus is duplicative.
`
`Objections
`Exhibit
`Exhibit 2017 FRE 402: The exhibit includes information that is not relevant to
`
`any ground upon which trial was instituted.
`
`FRE 403: The exhibit’s probative value to any ground upon which
`
`trial was instituted is substantially outweighed by the danger of
`
`unfair prejudice, confusing the issues, undue delay, wasting time,
`
`or needlessly presenting cumulative evidence.
`
`Lack of Foundation: Patent Owner has not provided sufficient
`
`explanation of what the exhibit is or what it allegedly shows.
`
`Exhibit 2018 FRE 402: The exhibit includes information that is not relevant to
`
`any ground upon which trial was instituted.
`
`FRE 403: The exhibit’s probative value to any ground upon which
`
`trial was instituted is substantially outweighed by the danger of
`
`unfair prejudice, confusing the issues, undue delay, wasting time,
`
`or needlessly presenting cumulative evidence.
`
`Lack of Foundation: Patent Owner has not provided sufficient
`
`explanation of what the exhibit is or what it allegedly shows.
`
`Exhibit 2019 FRE 402: The exhibit includes information that is not relevant to
`
`-2-
`
`
`
`
`Exhibit
`
`Case No. IPR2017-01321
`
`Objections
`any ground upon which trial was instituted.
`
`FRE 403: The exhibit’s probative value to any ground upon which
`
`trial was instituted is substantially outweighed by the danger of
`
`unfair prejudice, confusing the issues, undue delay, wasting time,
`
`or needlessly presenting cumulative evidence.
`
`Lack of Foundation: Patent Owner has not provided sufficient
`
`explanation of what the exhibit is or what it allegedly shows.
`
`FRE 901: The exhibit has not been authenticated.
`
`Exhibit 2020 FRE 402: The exhibit includes information that is not relevant to
`
`any ground upon which trial was instituted.
`
`FRE 403: The exhibit’s probative value to any ground upon which
`
`trial was instituted is substantially outweighed by the danger of
`
`unfair prejudice, confusing the issues, undue delay, wasting time,
`
`or needlessly presenting cumulative evidence.
`
`Lack of Foundation: Patent Owner has not provided sufficient
`
`explanation of what the exhibit is or what it allegedly shows.
`
`FRE 901: The exhibit has not been authenticated.
`
`Exhibit 2022 FRE 402: The exhibit includes information that is not relevant to
`
`any ground upon which trial was instituted.
`
`-3-
`
`
`
`
`Exhibit
`
`Case No. IPR2017-01321
`
`Objections
`FRE 403: The exhibit’s probative value to any ground upon which
`
`trial was instituted is substantially outweighed by the danger of
`
`unfair prejudice, confusing the issues, undue delay, wasting time,
`
`or needlessly presenting cumulative evidence.
`
`Lack of Foundation: Patent Owner has not provided sufficient
`
`explanation of what the exhibit is or what it allegedly shows.
`
`Exhibit 2024 FRE 402: The exhibit includes information that is not relevant to
`
`any ground upon which trial was instituted.
`
`FRE 403: The exhibit’s probative value to any ground upon which
`
`trial was instituted is substantially outweighed by the danger of
`
`unfair prejudice, confusing the issues, undue delay, wasting time,
`
`or needlessly presenting cumulative evidence.
`
`Lack of Foundation: Patent Owner has not provided sufficient
`
`explanation of what the exhibit is or what it allegedly shows.
`
`FRE 901: The exhibit has not been authenticated.
`
`Exhibit 2031 FRE 403: The exhibit is a duplicate of Exhibit 1019 and no further
`
`statements are given for presenting cumulative evidence.
`
`
`
`-4-
`
`
`
`
`Ex. 2025 – Declaration of Jack Emert. Petitioner further objects to Exhibit
`
`Case No. IPR2017-01321
`
`2025 in its entirety to the extent it provides assertions without citation, and without
`
`laying foundation. Afton reserves its right to further challenge Dr. Emert’s
`
`testimony based on deposition of this individual. Afton reserves the right to move
`
`to exclude Exhibit 2025 in whole or in part. Petitioner objects to the following
`
`paragraphs of Ex. 2025:
`
`Paragraph Objections
`
`¶¶ 9, 47, 98,
`
`FRE 702. The statements and opinions set forth in these
`
`101, 156,
`
`paragraphs, including those regarding what was purportedly
`
`165
`
`“known”, “widely used,” “typical,” or “standard” are not based
`
`on sufficient facts or data.
`
`¶¶ 33, 35,
`
`FRE 702. The statements and opinions set forth in these
`
`37-39, 46
`
`paragraphs are based on an incorrect interpretation of
`
`Component G in Colclough and are not based on sufficient facts
`
`or data, and are not the result of the application of reliable
`
`scientific principles and methods.
`
`¶¶ 48, 51-57 FRE 402. These paragraphs cite to a document (Ex. 2014) that is
`
`irrelevant for purposes of establishing the state of the art and the
`
`and are thus irrelevant for purposes of establishing the state of the
`
`art and the beliefs of those of ordinary skill as of the ’274 patent’s
`
`-5-
`
`
`
`
`
`effective filing date.
`
`Case No. IPR2017-01321
`
`FRE 702. The statements and opinions set forth in these
`
`paragraphs are not based on sufficient facts or data, and are not
`
`the result of the application of reliable scientific principles and
`
`methods.
`
`FRE 802. These paragraphs improperly cite the out of court
`
`statements of Ex. 2014 to establish the truth of the matter
`
`asserted.
`
`¶¶ 48, 51,
`
`FRE 402. These paragraphs cite to documents (Ex. 2017, 2018,
`
`53, 56, 57
`
`2019, and/or 2020) that are irrelevant for purposes of establishing
`
`the state of the art and are thus irrelevant for purposes of
`
`establishing the state of the art and the beliefs of those of ordinary
`
`skill as of the ’274 Patent’s effective filing date.
`
`FRE 802. These paragraphs improperly cite the out of court
`
`statements of Ex. 2017, 2018, 2019, and/or 2020 to establish the
`
`truth of the matter asserted.
`
`¶¶ 58-60
`
`FRE 702. The statements and opinions regarding Colclough set
`
`forth in these paragraphs are not based on sufficient facts or
`
`data, and are not the result of the application of reliable scientific
`
`principles and methods.
`
`-6-
`
`
`
`
`¶¶ 64-68
`
`Case No. IPR2017-01321
`
`FRE 702. The statements and opinions regarding Nicholson set
`
`forth in these paragraphs are not based on sufficient facts or
`
`data, and are not the result of the application of reliable scientific
`
`principles and methods.
`
`¶¶ 69-73
`
`FRE 702. The statements and opinions regarding the ACEA
`
`2004 specification set forth in these paragraphs are not based on
`
`sufficient facts or data, and are not the result of the application of
`
`reliable scientific principles and methods.
`
`¶¶ 74-78
`
`FRE 702. The statements and opinions set forth in these
`
`paragraphs are not based on sufficient facts or data, and are not
`
`the result of the application of reliable scientific principles and
`
`methods.
`
`¶¶ 86 & 87 FRE 702. The statements and opinions set forth in these
`
`paragraphs, including those regarding what was purportedly
`
`“likely” are not based on sufficient facts or data, and are not the
`
`result of the application of reliable scientific principles and
`
`methods.
`
`¶¶ 90 & 91 FRE 702. The statements and opinions set forth in these
`
`paragraphs are not based on sufficient facts or data, and are not
`
`the result of the application of reliable scientific principles and
`
`-7-
`
`
`
`
`
`methods.
`
`Case No. IPR2017-01321
`
`¶¶ 95-99
`
`FRE 702. The statements and opinions set forth in these
`
`paragraphs, including those regarding what was purportedly
`
`“critical” are not based on sufficient facts or data, and are not the
`
`result of the application of reliable scientific principles and
`
`methods.
`
`FRE 802. These paragraphs improperly cite the out of court
`
`statements of Exs. 2016 and 2034 to establish the truth of the
`
`matter asserted.
`
`¶ 100
`
`FRE 702. The statements and opinions set forth in this
`
`paragraph, including the statements “any other determinable
`
`amount of nitrogen” and “small amount of nitrogen” are not
`
`based on sufficient facts or data, and are not the result of the
`
`application of reliable scientific principles and methods.
`
`¶¶ 102-107 FRE 702. The statements and opinions set forth in these
`
`paragraphs are not based on sufficient facts or data, and are not
`
`the result of the application of reliable scientific principles and
`
`methods.
`
`FRE 802. These paragraphs improperly cite the out of court
`
`statements of US Pat. No. 4,908,145 (Ex. 2007) to establish the
`
`-8-
`
`
`
`
`
`truth of the matter asserted.
`
`Case No. IPR2017-01321
`
`¶¶ 110-116 FRE 702. The statements and opinions set forth in these
`
`paragraphs, including those regarding what was purportedly
`
`“definitive nitrogen content” are not based on sufficient facts or
`
`data, and are not the result of the application of reliable scientific
`
`principles and methods.
`
`FRE 402/403. The table within paragraph 114 is irrelevant
`
`because it is labelled “Fetterman Example IV” and is not
`
`relevant to any ground upon which trial was instituted.
`
`¶¶ 132, 135,
`
`FRE 702. The statements and opinions regarding Colclough set
`
`139, 140
`
`forth in these paragraphs, including those regarding what was
`
`“off-limits” are not based on sufficient facts or data, and are not
`
`the result of the application of reliable scientific principles and
`
`methods.
`
`¶¶ 141-152,
`
`FRE 702. The statements and opinions regarding Nicholson set
`
`154-159
`
`forth in these paragraphs are not based on sufficient facts or
`
`data, and are not the result of the application of reliable scientific
`
`principles and methods.
`
`¶ 161
`
`FRE 402/403. This paragraph is irrelevant because the statement
`
`– “I agree that Fetterman neither anticipates nor renders obvious
`
`-9-
`
`
`
`
`
`Case No. IPR2017-01321
`
`proposed amended claims 14-25” – improperly implies that the
`
`Board considered the amended claims upon institution.
`
`¶¶ 161-163 FRE 402/403. These paragraphs are irrelevant, confusing and
`
`misleading because the statements refer to “Fetterman” without
`
`citing an Exhibit number and Dr. Emert considered two different
`
`Fetterman references (Ex. 1010 and Ex. 2032) in paragraph 159.
`
`¶¶ 162 &
`
`FRE 702. The statements and opinions set forth in these
`
`163
`
`paragraphs are not based on sufficient facts or data, and are not
`
`the result of the application of reliable scientific principles and
`
`methods.
`
`¶¶ 162 &
`
`FRE 402/403. These paragraphs are irrelevant because the
`
`167
`
`statement – “between 0.05 and 0.15 mass% magnesium” –
`
`misstates the claim range of magnesium in amended claim 14.
`
`¶ 163
`
`FRE 402/403. This paragraph is irrelevant, confusing and
`
`misleading because the statement – “[t]he ’274 patent claim’s
`
`require the opposite – a sulfur-free aminic or phenolic
`
`antioxidant” – misstates the claim language in ’274 Patent and is
`
`not relevant to amended claims 14-25.
`
`¶¶ 165 &
`
`FRE 402/403. These paragraphs are irrelevant, confusing and
`
`-10-
`
`
`
`
`
`166
`
`Case No. IPR2017-01321
`
`misleading because both “Arrowsmith ‘958” and “Arrowsmith
`
`‘985” are referred to in the paragraph without citing an Exhibit
`
`number.
`
`¶ 168
`
`FRE 402/403. This paragraph is irrelevant because the statement
`
`– “all the components required by the ’274 patent” – misstates
`
`the claim of ’274 Patent with the disclosure and is not relevant to
`
`amended claims 14-25.
`
`¶¶ 169, 171-
`
`FRE 702. The statements and opinions set forth in these
`
`180, 182-187
`
`paragraphs are not based on sufficient facts or data, and are not
`
`the result of the application of reliable scientific principles and
`
`methods.
`
`
`
`Petitioner maintains all of its objections to Exhibits 2001-2016 filed on
`
`August 8, 2017 to the evidence filed with Patent Owner’s Preliminary Response.
`
`Petitioner reserves the right to move to exclude the above referenced
`
`Exhibits in whole or in part.
`
`-11-
`
`
`
`
`In view of these objections, Petitioner also objects to any other testimony or
`
`Case No. IPR2017-01321
`
`arguments that cite or rely on any of the above mentioned exhibits.
`
`Respectfully,
`
`By: /s/ Matias Ferrario
`Matias Ferrario
`Registration No. 51,082
`Lead Counsel for Petitioner
`
`
`
`
`Dated: February 9, 2018
`
`Kilpatrick Townsend & Stockton LLP
`1001 West Fourth Street
`Winston-Salem, NC 27101-2400
`Telephone: 336 607 7475
`Facsimile: 336 734 2651
`
`
`
`
`
`
`
`
`-12-
`
`
`
`
`
`Case No. IPR2017-01321
`
`
`CERTIFICATE OF SERVICE
`
`
`
`The undersigned certifies that on February 9, 2018, a complete copy of this
`
`NOTICE OF PETITIONER’S OBJECTIONS TO PATENT OWNER’S
`
`RESPONSE EVIDENCE, was served via email on Counsel for Patent Owners at
`
`the email addresses listed below:
`
`Elizabeth A. Gardner, Orrick, Herrington & Sutcliffe LLP
`51 West 52nd Street
`New York, NY 10019
`egardner@orrick.com
`
`K. Patrick Herman, Orrick, Herrington & Sutcliffe LLP
`pherman@orrick.com
`
`Don Daybell, Orrick, Herrington & Sutcliffe LLP
`ddaybell@orrick.com
`
`E1APTABDocket@orrick.com; P52PTABDocket@orrick.com; and
`D2DPTABDocket@orrick.com
`
`Respectfully,
`By: /s/ Matias Ferrario
`Matias Ferrario
`Registration No. 51,082
`Lead Counsel for Petitioner
`
`
`
`
`
`Kilpatrick Townsend & Stockton LLP
`1001 West Fourth Street
`Winston-Salem, NC 27101-2400
`Telephone: 336 607 7475
`Facsimile: 336 734 2651
`
`-13-
`
`